Emerson Luiz Botelho Lourenço
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Emerson Luiz Botelho Lourenço has a total of 192 co-authors. Here are the top co-authors by number of shared publications:
- Guilherme Donadel
PhD Program in Animal Science with Emphasis on Bioactive Products, Universidade Paranaense (UNIPAR), Umuarama 87502-210, Paraná, Brazil
21 shared publications - Mariana Dalmagro
Postgraduate Program in Biotechnology Applied to Agriculture, University of Paraná, Umuarama 87502-210, Paraná, Brazil
17 shared publications - Giuliana Zardeto
Universidade Paranaense
15 shared publications - Odair Alberton
Postgraduate Program in Biotechnology Applied to Agriculture, Universidade Paranaense (UNIPAR), Umuarama 87502-210, Paraná, Brazil
15 shared publications - Daniela de Cassia Faglioni Boleta-Ceranto
Universidade Paranaense
13 shared publications - Jaqueline Hoscheid
Postgraduate Program in Biotechnology Applied to Agriculture, Universidade Paranaense (UNIPAR), Umuarama 87502-210, Paraná, Brazil
12 shared publications
Latest Publications
- Open Access
- 9 October 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (10) , 1599
Cardioprotective Effect of Nanoencapsulated α-Amyrin in Spontaneously Hypertensive Rats with Metabolic Syndrome
Background/Objectives: Metabolic syndrome (MS) encompasses a cluster of disorders that significantly increase cardiovascular risk. While α-amyrin exhibits antioxidant and anti-inflammatory properties, its poor aqueous solubility and low oral bioavailability hinder its clinical use. This study evaluated the cardioprotective effects of α-amyrin-loaded polymeric nanocapsules (NCαA) in spontaneously hypertensive rats (SHR) with sucrose-induced MS. Methods: First, NCαA was prepared via interfacial deposition of a preformed polymer following organic solvent displacement. The formulation was characterized for particle size, zeta potential, morphology, encapsulation efficiency, and storage stability. Spontaneously hypertensive rats (SHR) received 20% sucrose for 8 weeks and were treated daily by oral gavage for 28 days with NCαA (0.1, 0.3, or 1 mg/kg), unformulated α-amyrin (1 mg/kg), hydrochlorothiazide (25 mg/kg), vehicle, or blank nanocapsules. Cardiovascular, electrocardiographic, echocardiographic, vascular, renal, and biochemical parameters were subsequently assessed. Results: Polymeric NCαA showed spherical and uniform morphology (195.10 ± 1.55 nm; PDI: 0.144; zeta potential: −52.60 mV), 85.85% encapsulation efficiency, efficient sustained release, and 90-day shelf-life stability. In vivo, MS control rats exhibited significant weight gain, hypertension, increased S-wave negative deflection depth, reduced ejection fraction, impaired acetylcholine-mediated vasodilation, depressed serum nitrite, and elevated malondialdehyde. Treatment with NCαA (particularly at 0.3 and 1 mg/kg), unlike unformulated α-amyrin, prevented excessive weight gain, normalized blood pressure, reversed electrophysiological/echocardiographic markers of cardiac overload, restored nitric oxide bioavailability, attenuated lipid peroxidation, and maintained renal hydroelectrolytic balance. Conclusions: Polymeric nanoencapsulation yielded stable nanocapsules with high sustained release, overcoming the biopharmaceutical limitations of α-amyrin. NCαA provides comprehensive cardioprotection against MS-induced damage, representing a promising multi-target strategy for cardiometabolic disorders.
- 9 October 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (10) , 1599
Open AccessCardioprotective Effect of Nanoencapsulated α-Amyrin in Spontaneously Hypertensive Rats with Metabolic Syndrome
Background/Objectives: Metabolic syndrome (MS) encompasses a cluster of disorders that significantly increase cardiovascular risk. While α-amyrin exhibits antioxidant and anti-inflammatory properties, its poor aqueous solubility and low oral bioavailability hinder its clinical use. This study evaluated the cardioprotective effects of α-amyrin-loaded polymeric nanocapsules (NCαA) in spontaneously hypertensive rats (SHR) with sucrose-induced MS. Methods: First, NCαA was prepared via interfacial deposition of a preformed polymer following organic solvent displacement. The formulation was characterized for particle size, zeta potential, morphology, encapsulation efficiency, and storage stability. Spontaneously hypertensive rats (SHR) received 20% sucrose for 8 weeks and were treated daily by oral gavage for 28 days with NCαA (0.1, 0.3, or 1 mg/kg), unformulated α-amyrin (1 mg/kg), hydrochlorothiazide (25 mg/kg), vehicle, or blank nanocapsules. Cardiovascular, electrocardiographic, echocardiographic, vascular, renal, and biochemical parameters were subsequently assessed. Results: Polymeric NCαA showed spherical and uniform morphology (195.10 ± 1.55 nm; PDI: 0.144; zeta potential: −52.60 mV), 85.85% encapsulation efficiency, efficient sustained release, and 90-day shelf-life stability. In vivo, MS control rats exhibited significant weight gain, hypertension, increased S-wave negative deflection depth, reduced ejection fraction, impaired acetylcholine-mediated vasodilation, depressed serum nitrite, and elevated malondialdehyde. Treatment with NCαA (particularly at 0.3 and 1 mg/kg), unlike unformulated α-amyrin, prevented excessive weight gain, normalized blood pressure, reversed electrophysiological/echocardiographic markers of cardiac overload, restored nitric oxide bioavailability, attenuated lipid peroxidation, and maintained renal hydroelectrolytic balance. Conclusions: Polymeric nanoencapsulation yielded stable nanocapsules with high sustained release, overcoming the biopharmaceutical limitations of α-amyrin. NCαA provides comprehensive cardioprotection against MS-induced damage, representing a promising multi-target strategy for cardiometabolic disorders.
- Open Access
- 2 October 2026
- Published by MDPI AG in Nutraceuticals
- Vol. 6 (4) , 66
Influence of Extraction Technique and Solvent on the Recovery of Bioactive Compounds from Eugenia uniflora L. Fruits: Antioxidant, Antimicrobial, and UHPLC-MS/MS Characterization
Fruits of Eugenia uniflora L. are rich in phenolic compounds and flavonoids, highlighting their potential as a source of bioactive compounds for nutraceutical development; however, extraction conditions can substantially influence the chemical composition and biological activity of the resulting extracts. This study evaluated the effects of extraction technique and solvent on the bioactive potential of E. uniflora fruit extracts. Powdered fruits were extracted by maceration, infusion, infusion followed by ethanol precipitation, and high-shear homogenization-assisted extraction (HSH) using water or 70% ethanol. Extracts were evaluated for yield, antioxidant capacity (DPPH, ABTS•+, and FRAP), antimicrobial activity against six species, and chemical composition by UHPLC–MS/MS. HSH with 70% ethanol exhibited the highest DPPH (54.16 µmol Trolox equivalents g−1) and FRAP (96.83 µmol Fe2+ g−1) responses, whereas ethanolic maceration showed the highest ABTS•+ scavenging capacity (170.59 µmol Trolox equivalents g−1). The ethanolic extracts showed greater antibacterial activity, particularly against E. coli (MIC = 6.51 µg mL−1) and S. epidermidis (MIC = 15.63 µg mL−1). UHPLC–MS/MS revealed diverse metabolites, with citric acid, quinic acid, and quercitrin showing prominent chromatographic peak areas, alongside other flavonoids, phenolic compounds, and organic acids. Overall, HSH with 70% ethanol provided the most balanced performance, supporting its potential as an efficient strategy for obtaining E. uniflora extracts with nutraceutical potential.
- 2 October 2026
- Published by MDPI AG in Nutraceuticals
- Vol. 6 (4) , 66
Open AccessInfluence of Extraction Technique and Solvent on the Recovery of Bioactive Compounds from Eugenia uniflora L. Fruits: Antioxidant, Antimicrobial, and UHPLC-MS/MS Characterization
Fruits of Eugenia uniflora L. are rich in phenolic compounds and flavonoids, highlighting their potential as a source of bioactive compounds for nutraceutical development; however, extraction conditions can substantially influence the chemical composition and biological activity of the resulting extracts. This study evaluated the effects of extraction technique and solvent on the bioactive potential of E. uniflora fruit extracts. Powdered fruits were extracted by maceration, infusion, infusion followed by ethanol precipitation, and high-shear homogenization-assisted extraction (HSH) using water or 70% ethanol. Extracts were evaluated for yield, antioxidant capacity (DPPH, ABTS•+, and FRAP), antimicrobial activity against six species, and chemical composition by UHPLC–MS/MS. HSH with 70% ethanol exhibited the highest DPPH (54.16 µmol Trolox equivalents g−1) and FRAP (96.83 µmol Fe2+ g−1) responses, whereas ethanolic maceration showed the highest ABTS•+ scavenging capacity (170.59 µmol Trolox equivalents g−1). The ethanolic extracts showed greater antibacterial activity, particularly against E. coli (MIC = 6.51 µg mL−1) and S. epidermidis (MIC = 15.63 µg mL−1). UHPLC–MS/MS revealed diverse metabolites, with citric acid, quinic acid, and quercitrin showing prominent chromatographic peak areas, alongside other flavonoids, phenolic compounds, and organic acids. Overall, HSH with 70% ethanol provided the most balanced performance, supporting its potential as an efficient strategy for obtaining E. uniflora extracts with nutraceutical potential.
- Open Access
Impact of Curcuma longa on Hematopoiesis and Splenic Mass in an Animal Model Undergoing Docetaxel Chemotherapy
(1) Background: Chemotherapy-induced hematological toxicity remains a major limitation to treatment continuity. Docetaxel is widely used in solid tumors due to its clinical efficacy, despite cumulative bone marrow suppression and splenic alterations. Curcuma longa is a phytochemical with antioxidant and anti-inflammatory properties that may confer cytoprotective effects on hematopoietic tissues. (2) Methods: One hundred and five male Wistar rats were randomly allocated into five treatment groups and evaluated at 7, 14, and 21 days. Animals received placebo, docetaxel alone, or docetaxel combined with Curcuma longa at doses of 25, 50, or 500 mg/kg/day. Post-treatment hematological parameters and relative spleen weight were analyzed using one-way ANOVA and Tukey’s post hoc test. (3) Results: Docetaxel induced progressive reductions in red blood cell count, hemoglobin, hematocrit, leukocytes, and platelets, with greater severity at day 21. Curcuma longa co-treatment partially mitigated these alterations in a dose- and time-dependent manner. Intermediate doses (25–50 mg/kg) showed the most consistent hematoprotective effects. High-dose treatment (500 mg/kg) was associated with no statistically significant change in relative spleen weight. (4) Conclusions: Curcuma longa partially mitigated docetaxel-induced hematological toxicity and modulated splenic responses in this experimental model. These findings support further translational studies on chemotherapy-induced hematological toxicity to clarify the role of Curcuma longa as a low-toxicity strategy.
Open AccessImpact of Curcuma longa on Hematopoiesis and Splenic Mass in an Animal Model Undergoing Docetaxel Chemotherapy
(1) Background: Chemotherapy-induced hematological toxicity remains a major limitation to treatment continuity. Docetaxel is widely used in solid tumors due to its clinical efficacy, despite cumulative bone marrow suppression and splenic alterations. Curcuma longa is a phytochemical with antioxidant and anti-inflammatory properties that may confer cytoprotective effects on hematopoietic tissues. (2) Methods: One hundred and five male Wistar rats were randomly allocated into five treatment groups and evaluated at 7, 14, and 21 days. Animals received placebo, docetaxel alone, or docetaxel combined with Curcuma longa at doses of 25, 50, or 500 mg/kg/day. Post-treatment hematological parameters and relative spleen weight were analyzed using one-way ANOVA and Tukey’s post hoc test. (3) Results: Docetaxel induced progressive reductions in red blood cell count, hemoglobin, hematocrit, leukocytes, and platelets, with greater severity at day 21. Curcuma longa co-treatment partially mitigated these alterations in a dose- and time-dependent manner. Intermediate doses (25–50 mg/kg) showed the most consistent hematoprotective effects. High-dose treatment (500 mg/kg) was associated with no statistically significant change in relative spleen weight. (4) Conclusions: Curcuma longa partially mitigated docetaxel-induced hematological toxicity and modulated splenic responses in this experimental model. These findings support further translational studies on chemotherapy-induced hematological toxicity to clarify the role of Curcuma longa as a low-toxicity strategy.
- Open Access
- 18 November 2025
- Published by MDPI AG in Preprints.org
Experimental Evaluation of Curcuma longa in Docetaxel-Induced Systemic Toxicity: Functional Hepatorenal and Target Organ Analysis
Docetaxel is a widely used chemotherapeutic agent effective against sol-id tumors, but its clinical use is limited by systemic toxicities, especially hepatotoxicity and nephrotoxicity. Curcuma longa, a phytochemical with antioxidant and anti-inflammatory properties, may offer organo-protective effects. Objective: To evaluate the protective effects of orally administered Curcuma longa against docetaxel-induced systemic toxicity in Wistar rats. Methods: Male Wistar rats were assigned to 5 subgroups (n=7/group) and treated for 7, 14, or 21 days with placebo, docetaxel (2.5 mg/kg, i.p.), or docetaxel combined with Curcuma longa (25, 50, or 500 mg/kg/day, oral). Serum biomarkers of hepatic function (Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT_, bilirubins) and renal function (urea, creatinine, electrolytes) were evaluated using summary measures, ANOVA, and Tukey’s post-hoc test, in addition to the relative weights of the liver, kidneys, heart, lungs, and small intes-tine. Results: Docetaxel induced significant elevations in hepatic and renal biomarkers and altered organ weights. Curcuma longa co-treatment attenuated these effects in a dose- and time-dependent man-ner. The 50 mg/kg dose consistently provided optimal protection. High-dose treatment was associated with marked splenic and intestinal hy-pertrophy. Conclusion: Curcuma longa demonstrates cytoprotective po-tential against docetaxel-induced toxicity, likely via Nrf2, NF-κB, and PI3K/Akt modulation. These findings support further translational re-search on Curcuma longa as an adjuvant in oncologic therapy.
- 18 November 2025
- Published by MDPI AG in Preprints.org
Open AccessExperimental Evaluation of Curcuma longa in Docetaxel-Induced Systemic Toxicity: Functional Hepatorenal and Target Organ Analysis
Docetaxel is a widely used chemotherapeutic agent effective against sol-id tumors, but its clinical use is limited by systemic toxicities, especially hepatotoxicity and nephrotoxicity. Curcuma longa, a phytochemical with antioxidant and anti-inflammatory properties, may offer organo-protective effects. Objective: To evaluate the protective effects of orally administered Curcuma longa against docetaxel-induced systemic toxicity in Wistar rats. Methods: Male Wistar rats were assigned to 5 subgroups (n=7/group) and treated for 7, 14, or 21 days with placebo, docetaxel (2.5 mg/kg, i.p.), or docetaxel combined with Curcuma longa (25, 50, or 500 mg/kg/day, oral). Serum biomarkers of hepatic function (Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT_, bilirubins) and renal function (urea, creatinine, electrolytes) were evaluated using summary measures, ANOVA, and Tukey’s post-hoc test, in addition to the relative weights of the liver, kidneys, heart, lungs, and small intes-tine. Results: Docetaxel induced significant elevations in hepatic and renal biomarkers and altered organ weights. Curcuma longa co-treatment attenuated these effects in a dose- and time-dependent man-ner. The 50 mg/kg dose consistently provided optimal protection. High-dose treatment was associated with marked splenic and intestinal hy-pertrophy. Conclusion: Curcuma longa demonstrates cytoprotective po-tential against docetaxel-induced toxicity, likely via Nrf2, NF-κB, and PI3K/Akt modulation. These findings support further translational re-search on Curcuma longa as an adjuvant in oncologic therapy.
- 23 January 2025
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 20 (1) , 1-15
Polymeric Film Loaded with Plinia cauliflora Peels Extract has a Differential Curative Effect on Injuries
- 23 January 2025
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 20 (1) , 1-15
Polymeric Film Loaded with Plinia cauliflora Peels Extract has a Differential Curative Effect on Injuries
- Open Access
Nitric Oxide and Small and Intermediate Calcium-Activated Potassium Channels Mediate the Vasodilation Induced by Apigenin in the Resistance Vessels of Hypertensive Rats
Background: Apigenin (4′,5,7-trihydroxyflavone), a flavonoid with potential cardiovascular benefits, has unclear mechanisms of action. This study investigates its effects on vascular function in Spontaneously Hypertensive Rats (SHRs). Methods: Mesenteric vascular beds (MVBs) were isolated from SHRs and perfused with increasing doses of apigenin after pre-contraction with phenylephrine. To explore the mechanisms, different MVBs were pre-perfused with antagonists and inhibitors, including indomethacin, L-NAME, and potassium channel blockers (tetraethylammonium, a non-specific potassium channel blocker; glibenclamide, an ATP-sensitive potassium channel blocker; 4-aminopyridine, a voltage-gated potassium channel blocker; charybdotoxin a selective intermediate-conductance calcium-activated potassium channel blocker; and apamin, a selective small-conductance calcium-activated potassium channel blocker). Results: Apigenin induced a dose-dependent reduction in perfusion pressure in MVBs with intact endothelium, an effect abolished by endothelium removal. L-NAME reduced apigenin-induced vasodilation by approximately 40%. The vasodilatory effect was blocked by potassium chloride and tetraethylammonium. The inhibition of small and intermediate calcium-activated potassium channels with charybdotoxin and apamin reduced apigenin-induced vasodilation by 50%, and a combination of these blockers with L-NAME completely inhibited the effect. Conclusions: Apigenin promotes vasodilation in resistance arteries through endothelial nitric oxide and calcium-activated potassium channels. These findings suggest that apigenin could have therapeutic potential in cardiovascular disease, warranting further clinical research.
Open AccessNitric Oxide and Small and Intermediate Calcium-Activated Potassium Channels Mediate the Vasodilation Induced by Apigenin in the Resistance Vessels of Hypertensive Rats
Background: Apigenin (4′,5,7-trihydroxyflavone), a flavonoid with potential cardiovascular benefits, has unclear mechanisms of action. This study investigates its effects on vascular function in Spontaneously Hypertensive Rats (SHRs). Methods: Mesenteric vascular beds (MVBs) were isolated from SHRs and perfused with increasing doses of apigenin after pre-contraction with phenylephrine. To explore the mechanisms, different MVBs were pre-perfused with antagonists and inhibitors, including indomethacin, L-NAME, and potassium channel blockers (tetraethylammonium, a non-specific potassium channel blocker; glibenclamide, an ATP-sensitive potassium channel blocker; 4-aminopyridine, a voltage-gated potassium channel blocker; charybdotoxin a selective intermediate-conductance calcium-activated potassium channel blocker; and apamin, a selective small-conductance calcium-activated potassium channel blocker). Results: Apigenin induced a dose-dependent reduction in perfusion pressure in MVBs with intact endothelium, an effect abolished by endothelium removal. L-NAME reduced apigenin-induced vasodilation by approximately 40%. The vasodilatory effect was blocked by potassium chloride and tetraethylammonium. The inhibition of small and intermediate calcium-activated potassium channels with charybdotoxin and apamin reduced apigenin-induced vasodilation by 50%, and a combination of these blockers with L-NAME completely inhibited the effect. Conclusions: Apigenin promotes vasodilation in resistance arteries through endothelial nitric oxide and calcium-activated potassium channels. These findings suggest that apigenin could have therapeutic potential in cardiovascular disease, warranting further clinical research.
- Open Access
- 4 October 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (10) , 1294
Development and Characterization of Film-Forming Solution Loaded with Syzygium cumini (L.) Skeels for Topical Application in Post-Surgical Therapies
Background/Objectives: Considering the antioxidant and antimicrobial properties attributed to compounds in Syzygium cumini extract, this research aimed to advance postoperative therapeutic innovations. Specifically, the study assessed the physicochemical properties of a film-forming solution (FFS) incorporated with S. cumini, evaluating its therapeutic potential for postoperative applications. Methods: The S. cumini extract was meticulously characterized to determine its chemical composition, with particular emphasis on the concentration of phenolic compounds. Antioxidant and antimicrobial assays were conducted to assess the extract’s efficacy in these domains. Following this, an FFS containing S. cumini was formulated and evaluated comprehensively for skin adhesion, mechanical and barrier properties, and thermal behavior. Results: The antioxidant and antimicrobial activities of the S. cumini extract demonstrated promising results, indicating its potential utility as an adjunct in postoperative care. The developed FFS exhibited favorable physicochemical properties for topical application, including adequate skin adhesion and appropriate pH levels. Moreover, chemical and thermal analyses confirmed the formulation’s stability and the retention of the extract’s beneficial properties. Conclusions: Overall, the findings suggest that the S. cumini-loaded FFS holds significant potential as a valuable therapeutic tool for post-surgical management.
- 4 October 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (10) , 1294
Open AccessDevelopment and Characterization of Film-Forming Solution Loaded with Syzygium cumini (L.) Skeels for Topical Application in Post-Surgical Therapies
Background/Objectives: Considering the antioxidant and antimicrobial properties attributed to compounds in Syzygium cumini extract, this research aimed to advance postoperative therapeutic innovations. Specifically, the study assessed the physicochemical properties of a film-forming solution (FFS) incorporated with S. cumini, evaluating its therapeutic potential for postoperative applications. Methods: The S. cumini extract was meticulously characterized to determine its chemical composition, with particular emphasis on the concentration of phenolic compounds. Antioxidant and antimicrobial assays were conducted to assess the extract’s efficacy in these domains. Following this, an FFS containing S. cumini was formulated and evaluated comprehensively for skin adhesion, mechanical and barrier properties, and thermal behavior. Results: The antioxidant and antimicrobial activities of the S. cumini extract demonstrated promising results, indicating its potential utility as an adjunct in postoperative care. The developed FFS exhibited favorable physicochemical properties for topical application, including adequate skin adhesion and appropriate pH levels. Moreover, chemical and thermal analyses confirmed the formulation’s stability and the retention of the extract’s beneficial properties. Conclusions: Overall, the findings suggest that the S. cumini-loaded FFS holds significant potential as a valuable therapeutic tool for post-surgical management.
- Open Access
- 1 October 2024
- Published by Brazilian Journals in Caderno Pedagógico
- Vol. 21 (10) , e9995
Successful treatment of two capillary psoriasis patients with cream containing Plinia cauliflora: a case report
Psoriasis is a chronic inflammatory skin condition that can affect any area of the body. It is characterized by reddish, scaling and erythematous lesions, being psoriasis vulgaris or plaque psoriasis the main form of clinical presentation of this disease. The existence of several adverse effects associated with the drugs already used in the treatment of this dermatosis stimulates studies focusing on the development of alternative therapies for its treatment. Plinia cauliflora (jabuticaba) is rich in flavonoids and has shown to have anti-inflammatory, antioxidant, antibacterial and anti-proliferative actions. The aim of this study was to evaluate the topical effect of P. cauliflora on skin lesions resulting from plaque psoriasis through case reports of six patients with psoriasis vulgaris who had lesions on the scalp or on both elbows and had not used topical or oral corticoids for at least four weeks. The selected regions were treated with P. cauliflora cream for four weeks and their evolution was followed through weekly photographs. P. cauliflora cream showed to have an anti-psoriatic effect, being observed in the volunteers a mean reduction of erythema in 33.3%, infiltration in 50% and local symptoms, measured through the Visual Analog Scale in 33.9%. Despite the promising effects of P. cauliflora, clinical studies with a larger number of volunteers are recommended to confirm its scientific validity.
- 1 October 2024
- Published by Brazilian Journals in Caderno Pedagógico
- Vol. 21 (10) , e9995
Open AccessSuccessful treatment of two capillary psoriasis patients with cream containing Plinia cauliflora: a case report
Psoriasis is a chronic inflammatory skin condition that can affect any area of the body. It is characterized by reddish, scaling and erythematous lesions, being psoriasis vulgaris or plaque psoriasis the main form of clinical presentation of this disease. The existence of several adverse effects associated with the drugs already used in the treatment of this dermatosis stimulates studies focusing on the development of alternative therapies for its treatment. Plinia cauliflora (jabuticaba) is rich in flavonoids and has shown to have anti-inflammatory, antioxidant, antibacterial and anti-proliferative actions. The aim of this study was to evaluate the topical effect of P. cauliflora on skin lesions resulting from plaque psoriasis through case reports of six patients with psoriasis vulgaris who had lesions on the scalp or on both elbows and had not used topical or oral corticoids for at least four weeks. The selected regions were treated with P. cauliflora cream for four weeks and their evolution was followed through weekly photographs. P. cauliflora cream showed to have an anti-psoriatic effect, being observed in the volunteers a mean reduction of erythema in 33.3%, infiltration in 50% and local symptoms, measured through the Visual Analog Scale in 33.9%. Despite the promising effects of P. cauliflora, clinical studies with a larger number of volunteers are recommended to confirm its scientific validity.
- 30 March 2024
- Published by MS-Editions in Boletin Latinoamericano Y Del Caribe de Plantas Medicinales Y Aromaticas
- Vol. 23 (2) , 229-247
Effect of Casearia sylvestrison the obliteration of dentinal tubules and the control of dental sensitivity
The present study evaluated the efficacy of the mineralizing action of Casearia sylvestris ethanolic extract on bovine dentin blocks in its pure form and in dental paste, through scanning electron microscopy. The dentin blocks were immersed in artificial saliva and incubated at 37°C for 7 days. Subsequently, six groups were treated with different test substances and analysed qualitatively and quantitatively at 30 and 60 days. The tests used were Kruskal-Wallis and Dunn's. Shapiro-Wilk and ANOVA. The qualitative analysis at 30 days showed a difference between the groups treated with ethanolic extract and toothpaste. Quantitatively, at 30 days, treatment with ethanolic extract of Casearia showed a greater number of open dentinal tubules. At 60 days, the difference persisted only for the blocks treated with toothpaste. The results obtained indicated that there is a positive relationship between the use of Casearia sylvestris and obliteration of dentinal tubules.
- 30 March 2024
- Published by MS-Editions in Boletin Latinoamericano Y Del Caribe de Plantas Medicinales Y Aromaticas
- Vol. 23 (2) , 229-247
Effect of Casearia sylvestrison the obliteration of dentinal tubules and the control of dental sensitivity
The present study evaluated the efficacy of the mineralizing action of Casearia sylvestris ethanolic extract on bovine dentin blocks in its pure form and in dental paste, through scanning electron microscopy. The dentin blocks were immersed in artificial saliva and incubated at 37°C for 7 days. Subsequently, six groups were treated with different test substances and analysed qualitatively and quantitatively at 30 and 60 days. The tests used were Kruskal-Wallis and Dunn's. Shapiro-Wilk and ANOVA. The qualitative analysis at 30 days showed a difference between the groups treated with ethanolic extract and toothpaste. Quantitatively, at 30 days, treatment with ethanolic extract of Casearia showed a greater number of open dentinal tubules. At 60 days, the difference persisted only for the blocks treated with toothpaste. The results obtained indicated that there is a positive relationship between the use of Casearia sylvestris and obliteration of dentinal tubules.
- Open Access
- 15 March 2024
- Published by Seven Events
- p. 485-500
Epidemiological profile of patients with psoriasis
Psoriasis is a disease that affects 2 to 3% of the world's population. It is a chronic, non-communicable, painful, and disabling disease for which there is no cure. Thus, this study aims to describe the epidemiological profile, quality of life, and pharmacotherapy of patients with psoriasis. For this, a descriptive and quantitative cross-sectional study was conducted using online questionnaires that were applied to patients with psoriasis. The questionnaire included questions about socio-demographic data (gender, color, schooling, marital status), quality of life with questions related to day-to-day actions and pharmacotherapy (name of the drug, adverse reactions). We interviewed 554 individuals with a mean age of 38.72 years, with predominance of females (82.2%), white (70.1%) and with complete higher education (39.4%). The main clinical manifestations reported were scaling, itching and redness in the lesion regions. An average of 14.88 were obtained to evaluate the quality of life by the dermatology life qualify methodology. This disease causes negative impacts on patients' quality of life, mainly due to the development of other comorbidities (anxiety and depression); With this study, we confirm how psoriasis affects the quality of life of patients, since stigmatization of the individual in social environments and the adverse effects caused by drugs, in addition to promoting the appearance of other comorbidities. DOI:https://doi.org/10.56238/sevened2024.001-040 A psoríase é uma doença que acomete de 2 a 3% da população mundial. Trata-se de uma doença crônica, não transmissível, dolorosa e incapacitante para a qual não há cura. Desta forma, este trabalho tem o objetivo de descrever o perfil epidemiológico, qualidade de vida e a farmacoterapia de pacientes com psoríase. Para isso, foi realizado um estudo transversal descritivo e quantitativo empregando questionários on-line que foram aplicados em pacientes com psoríase. O questionário contou com perguntas sobre dados sociodemográfico (sexo, cor, escolaridade, estado cívil), qualidade de vida com questões relacionado as ações do dia-a-dia e farmacoterapia (nome do medicamento, reações adversos). Foram entrevistados 554 indivíduos com idade média de 38,72 anos, com predominância do sexo feminino (82,2%), de cor branca (70,1%) e com ensino superior completo (39,4%). As principais manifestações clínicas relatadas foram descamação, prurido e vermelhidão nas regiões de lesão. Na avaliação da qualidade de vida pela metodologia dermatology life qualify obteve-se uma média de 14,88. Essa doença ocasiona impactos negativos sobre a qualidade de vida dos pacientes, principalmente, devido ao desenvolvimento de outras comorbidades (ansiedade e depressão), com esse estudo confirmamos como a psoríase afeta a qualidade de vida dos pacientes com psoríase desde estigmatização do indivíduo nos ambientes sociais, e os medicamentos causando efeitos adversos e além favorecer surgimentos de outras comorbidades. DOI:https://doi.org/10.56238/sevened2024.001-040
- 15 March 2024
- Published by Seven Events
- p. 485-500
Open AccessEpidemiological profile of patients with psoriasis
Psoriasis is a disease that affects 2 to 3% of the world's population. It is a chronic, non-communicable, painful, and disabling disease for which there is no cure. Thus, this study aims to describe the epidemiological profile, quality of life, and pharmacotherapy of patients with psoriasis. For this, a descriptive and quantitative cross-sectional study was conducted using online questionnaires that were applied to patients with psoriasis. The questionnaire included questions about socio-demographic data (gender, color, schooling, marital status), quality of life with questions related to day-to-day actions and pharmacotherapy (name of the drug, adverse reactions). We interviewed 554 individuals with a mean age of 38.72 years, with predominance of females (82.2%), white (70.1%) and with complete higher education (39.4%). The main clinical manifestations reported were scaling, itching and redness in the lesion regions. An average of 14.88 were obtained to evaluate the quality of life by the dermatology life qualify methodology. This disease causes negative impacts on patients' quality of life, mainly due to the development of other comorbidities (anxiety and depression); With this study, we confirm how psoriasis affects the quality of life of patients, since stigmatization of the individual in social environments and the adverse effects caused by drugs, in addition to promoting the appearance of other comorbidities. DOI:https://doi.org/10.56238/sevened2024.001-040 A psoríase é uma doença que acomete de 2 a 3% da população mundial. Trata-se de uma doença crônica, não transmissível, dolorosa e incapacitante para a qual não há cura. Desta forma, este trabalho tem o objetivo de descrever o perfil epidemiológico, qualidade de vida e a farmacoterapia de pacientes com psoríase. Para isso, foi realizado um estudo transversal descritivo e quantitativo empregando questionários on-line que foram aplicados em pacientes com psoríase. O questionário contou com perguntas sobre dados sociodemográfico (sexo, cor, escolaridade, estado cívil), qualidade de vida com questões relacionado as ações do dia-a-dia e farmacoterapia (nome do medicamento, reações adversos). Foram entrevistados 554 indivíduos com idade média de 38,72 anos, com predominância do sexo feminino (82,2%), de cor branca (70,1%) e com ensino superior completo (39,4%). As principais manifestações clínicas relatadas foram descamação, prurido e vermelhidão nas regiões de lesão. Na avaliação da qualidade de vida pela metodologia dermatology life qualify obteve-se uma média de 14,88. Essa doença ocasiona impactos negativos sobre a qualidade de vida dos pacientes, principalmente, devido ao desenvolvimento de outras comorbidades (ansiedade e depressão), com esse estudo confirmamos como a psoríase afeta a qualidade de vida dos pacientes com psoríase desde estigmatização do indivíduo nos ambientes sociais, e os medicamentos causando efeitos adversos e além favorecer surgimentos de outras comorbidades. DOI:https://doi.org/10.56238/sevened2024.001-040